France’s HRA Pharma SA is poised to establish a solid footing in the US consumer health market by acquiring from Germany’s Merz GmbH & Co. KGaA the popular Mederma OTC dermatology brand.
Through the deal - slated to close within the second quarter - HRA will gain the global rights to the...





